Cohort Studies in Cancer Epidemiology

The summary for the Cohort Studies in Cancer Epidemiology grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Cohort Studies in Cancer Epidemiology: The Division of Cancer Control and Population Sciences (DCCPS) of the National Cancer Institute (NCI) announces special receipt dates for R01 grant applications from investigators intending to initiate, competitively supplement, or competitively renew population-based epidemiologic or survivorship cohort studies of human cancers. The purpose of the Program Announcement (PA) is to coordinate the submission, review, and funding of population-based epidemiologic or survivorship cohort studies, and covers applications characterized by their cohort design and direct costs of $500,000 or more in any one study year. This PA represents a continuation of previous NCI policy, in that the NCI does not accept unsolicited applications at these budget levels for population-based cohorts. All usual NIH grants policies apply to these awards.

Federal Grant Title:	Cohort Studies in Cancer Epidemiology
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-04-011
Type of Funding:	Grant
CFDA Numbers:	93.399
CFDA Descriptions:	Cancer Control
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Oct 22, 2003
Creation Date:	Oct 22, 2003
Archive Date:	Dec 02, 2005
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Pop...; • Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical ...; • Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical ...; • Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials ...; • Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials ...; • Exploratory Grants for Behavioral Research in Cancer Control; • Decision Making in Cancer: Single-Event Decisions; • Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...